F3 Uranium Corp (TSXV: FUU) (OTCQB: FUUFF) ("F3" or "the Company") is pleased to announce initial scintillometer results from ...

The Company considers uranium mineralization with assay results of greater than 1.0 weight % U 3 O 8 as "high grade" and ...

Announced extraordinary 86% overall survival at 9 months in first-line pancreatic cancer patients treated with atebimetinib + mGnP - - Raised $225 million of financing, including $25 million private ...

Q3 2025 Earnings Call November 12, 2025 4:30 PM ESTCompany ParticipantsBenjamin Zeskind - Co-Founder, President, CEO ...

The new uranium target at Eureka is situated along trend of Namibia's "Alaskite Alley", a structural corridor within ...

Explore the evolving rare earth hypothesis, highlighting new findings on habitability and the conditions for complex life on ...

HD 10 is currently represented by Brannan’s father, Rep. Chuck Brannan, who is term-limited in 2026. A total of 230 Mayors, ...

The third quarter was truly transformational for Immuneering (IMRX). We announced extraordinary overall survival data from our ongoing Phase 2a ...

Clive Massey, President & CEO of Atomic Minerals, commented, "We are very pleased to have approval for 15 drill holes at ...

Q2 2026 Earnings Call Transcript November 10, 2025 Immunovant, Inc. misses on earnings expectations. Reported EPS is ...

Perspective Therapeutics, Inc. (“Perspective,” the “Company,” “we,” “us,” and “our”) (NYSE AMERICAN: CATX), a radiopharmaceutical development company that is pioneering advanced treatments for cancers ...